Global Alexipharmic Drugs Market
Global Alexipharmic Drugs Market by Application, by Route of Administration, by End-Users, and By Region
March 12, 2024 13:46 ET | Research and Markets
Dublin, March 12, 2024 (GLOBE NEWSWIRE) -- The "Global Alexipharmic Drugs Market by Application, by Route of Administration, by End-Users, and By Region" report has been added to ...
Global Antidote Market
Global Antidote Market Size, Share & Trends Analysis Report 2024-2030 - Snakebites and Surge in Number of Drug Overdoses Drives Demand for Antidotes
January 26, 2024 11:35 ET | Research and Markets
Dublin, Jan. 26, 2024 (GLOBE NEWSWIRE) -- The "Global Antidote Market Size, Share & Trends Analysis Report by Type (Chemical Antidote, Physical Antidote, Pharmacological Antidote), Route Of...
cmi_logo.png
[Latest] Global Naloxone Market Size/Share Worth USD 2,470.2 Million by 2032 at a 11% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
December 04, 2023 14:30 ET | Custom Market Insights
Austin, TX, USA, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Naloxone Market Size, Trends and Insights By Type (Injectable, Intranasal), By...
(ACMT) Toxicology Investigators Consortium (ToxIC)
Out-of-Hospital Naloxone Administration to be Studied in New Federally-Funded Project
October 02, 2023 11:31 ET | American College of Medical Toxicology
Phoenix, AZ, Oct. 02, 2023 (GLOBE NEWSWIRE) -- In September 2023, the FDA awarded the American College of Medical Toxicology’s (ACMT) Toxicology Investigators Consortium (ToxIC) through its Broad...
ARC logo.png
Naloxone Market Projected to Attain a Value of USD 3,036.8 Million by 2032, Exhibiting a CAGR of 10.5% between 2023 and 2032
September 27, 2023 10:17 ET | Acumen Research and Consulting
LOS ANGELES, Sept. 27, 2023 (GLOBE NEWSWIRE) -- The Naloxone Market is spearheading efforts to combat the opioid epidemic by providing advanced solutions for reversing opioid overdoses. The...
Adamis Pharmaceuticals logo
Adamis Pharmaceuticals Participated in White House Meeting Regarding Opioid Overdose Prevention
June 22, 2023 07:30 ET | Adamis Pharmaceuticals Corporation
SAN DIEGO, June 22, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company, today announced that Eboo Versi, MD, PhD, CEO of Adamis...
Adamis Pharmaceuticals logo
Adamis Pharmaceuticals Announces Closing of the Merger with DMK Pharmaceuticals
May 25, 2023 16:26 ET | Adamis Pharmaceuticals Corporation
DMK CEO, Ebrahim (Eboo) Versi, MD, PhD, named CEO and Chairman of the combined companyCombined company will have commercial products and a library of development candidates, including two clinical...
Adamis Pharmaceuticals logo
Adamis Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update
May 15, 2023 16:47 ET | Adamis Pharmaceuticals Corporation
SAN DIEGO, May 15, 2023 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP), a commercial-stage biopharmaceutical company focused on developing and commercializing products in...
22157.jpg
Insights on the Naloxone Global Market to 2030 - Increasing Prevalence of Opioid Overdoses Remains as The Most Impactful Driver
January 30, 2023 09:33 ET | Research and Markets
Dublin, Jan. 30, 2023 (GLOBE NEWSWIRE) -- The "Naloxone Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to...
IMG_0462.JPG
Heart to Heart CPR Raises Awareness of Ontario's NEW Workplace Naloxone Requirements Effective June 1, 2023
January 10, 2023 08:08 ET | Heart to Heart First Aid CPR Services Inc
TORONTO, Jan. 10, 2023 (GLOBE NEWSWIRE) -- As of June 1, 2023, the Occupational Health and Safety Act (OHSA) will require workplaces to have a naloxone kit if an employer becomes aware, or ought...